|
Volumn 26, Issue 4, 2000, Pages 307-312
|
Antenatal use of ambroxol for the prevention of infant respiratory distress syndrome
|
Author keywords
Ambroxol; Infant respiratory distress syndrome
|
Indexed keywords
AMBROXOL;
UTERUS SPASMOLYTIC AGENT;
ABNORMAL RESPIRATORY SOUND;
ADULT;
APGAR SCORE;
ARTICLE;
BRADYPNEA;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CYANOSIS;
DRUG EFFICACY;
DRUG SAFETY;
FEMALE;
FETUS OUTCOME;
GASTROINTESTINAL SYMPTOM;
HUMAN;
HYPOTENSION;
INCIDENCE;
NEONATAL RESPIRATORY DISTRESS SYNDROME;
NEWBORN;
NOSE CONGESTION;
PREMATURE FETUS MEMBRANE RUPTURE;
PREMATURE LABOR;
PRENATAL CARE;
PROPHYLAXIS;
PROSPECTIVE STUDY;
RESPIRATORY TRACT DISEASE;
TACHYCARDIA;
ADULT;
AMBROXOL;
APGAR SCORE;
DRUG ADMINISTRATION SCHEDULE;
EXPECTORANTS;
FEMALE;
FETAL MEMBRANES, PREMATURE RUPTURE;
HUMANS;
INFANT, NEWBORN;
INFUSIONS, INTRAVENOUS;
MALE;
PREGNANCY;
PRENATAL CARE;
PROSPECTIVE STUDIES;
PULMONARY SURFACTANTS;
RESPIRATORY DISTRESS SYNDROME, NEWBORN;
TREATMENT OUTCOME;
|
EID: 0033779634
PISSN: 13418076
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1447-0756.2000.tb01327.x Document Type: Article |
Times cited : (29)
|
References (20)
|